Cite
The Acceptance of Indirect Treatment Comparison Methods in Oncology by Health Technology Assessment Agencies in England, France, Germany, Italy, and Spain.
MLA
Macabeo, Bérengère, et al. “The Acceptance of Indirect Treatment Comparison Methods in Oncology by Health Technology Assessment Agencies in England, France, Germany, Italy, and Spain.” PharmacoEconomics - Open, vol. 8, no. 1, Jan. 2024, pp. 5–18. EBSCOhost, https://doi.org/10.1007/s41669-023-00455-6.
APA
Macabeo, B., Rotrou, T., Millier, A., François, C., & Laramée, P. (2024). The Acceptance of Indirect Treatment Comparison Methods in Oncology by Health Technology Assessment Agencies in England, France, Germany, Italy, and Spain. PharmacoEconomics - Open, 8(1), 5–18. https://doi.org/10.1007/s41669-023-00455-6
Chicago
Macabeo, Bérengère, Théophile Rotrou, Aurélie Millier, Clément François, and Philippe Laramée. 2024. “The Acceptance of Indirect Treatment Comparison Methods in Oncology by Health Technology Assessment Agencies in England, France, Germany, Italy, and Spain.” PharmacoEconomics - Open 8 (1): 5–18. doi:10.1007/s41669-023-00455-6.